Walleye Capital
EW icon

Walleye Capital’s Edwards Lifesciences EW Stock Holding History

Walleye Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.91M Sell
43,200
-6,300
-13% -$528K 0.01% 975
2026
Q1 		$3.96M Buy
49,500
+17,400
+54% +$1.43M 0.02% 956
2025
Q4 		$2.74M Buy
32,100
+25,400
+379% +$2.08M 0.01% 1609
2025
Q3 		$521K Buy
6,700
+6,300
+1,575% +$492K ﹤0.01% 2570
2025
Q2 		$31.3K Sell
400
-31,600
-99% -$2.36M ﹤0.01% 4159
2025
Q1 		$2.32M Sell
32,000
-10,300
-24% -$737K 0.01% 1309
2024
Q4 		$3.13M Buy
42,300
+20,700
+96% +$1.45M 0.01% 1395
2024
Q3 		$1.43M Sell
21,600
-17,600
-45% -$1.28M ﹤0.01% 2281
2024
Q2 		$3.62M Buy
39,200
+21,600
+123% +$1.91M 0.01% 1546
2024
Q1 		$1.68M Sell
17,600
-56,900
-76% -$4.78M ﹤0.01% 2125
2023
Q4 		$5.68M Buy
74,500
+37,900
+104% +$2.64M 0.01% 1022
2023
Q3 		$2.54M Sell
36,600
-8,100
-18% -$651K 0.01% 1548
2023
Q2 		$4.22M Buy
44,700
+18,600
+71% +$1.62M 0.02% 842
2023
Q1 		$2.16M Buy
+26,100
New +$2.05M 0.03% 676
2019
Q3 		– Sell
-42,600
Closed -$2.62M – 1986
2019
Q2 		$2.62M Buy
42,600
+35,400
+492% +$2.14M 0.29% 52
2019
Q1 		$459K Buy
+7,200
New +$411K 0.08% 413

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Walleye Capital's EW Position: Q2 2026 in Review

Walleye Capital reduced its Edwards Lifesciences (EW) stake by 79% in Q2 2026, selling an estimated $129K and leaving 416 shares worth $37.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4265.

Walleye Capital first reported a position in EW in Q1 2019 and has held it in 14 quarters since. The position peaked at $23.3M in Q4 2025. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Walleye Capital held 416 shares of Edwards Lifesciences worth $37.6K as of Q2 2026.
  • Walleye Capital sold 1,534 Edwards Lifesciences shares in Q2 2026, an estimated $129K.
  • Edwards Lifesciences made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #4265 holding.
  • Walleye Capital first reported a position in Edwards Lifesciences in Q1 2019 and has held it in 14 quarters since.
  • Walleye Capital's Edwards Lifesciences position peaked at $23.3M in Q4 2025.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.